Heartflow

1/ In the "gold rush" of medical AI, many platforms are racing to market. But in cardiology, the difference between a "good guess" and a "clinical standard" is the depth of the data behind it. Here is why data depth is the ultimate competitive differentiator. 👇

How can Heartflow Plaque Staging help personalize CAD risk assessment? Our Chief Medical Officer, Dr. Campbell Rogers, invites you to our Expert Theater* this afternoon at AHA Scientific Sessions 2026, featuring Drs. Leslee Shaw, Seth Martin, and Michael Gallagher. 📍 Heart Theater 1 | 3:15 PM CT Afterward, keep the conversation going at booth 711. *This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming.

We’re kicking off AHA #ScientificSessions26 in Chicago, and we’re so excited to be here. Our Chief Medical Officer, Dr. Campbell Rogers, shares what to look forward to over the next few days: ▸ Booth #711: Live Heartflow demos and Innovation Hub ▸ AHA Simulation Zone: Hands-on training workshops ▸ Sunday: Our Expert Theater* in Heart Theater 1 at p.m. ▸ Monday: New DECIDE 1-year and GAMEFILM registry data Come see us at our booth! *This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming. #AHA2026 #AIinHealthcare

Firefighters protect our communities. Who’s protecting their hearts? Our Chief Medical Officer, Dr. Campbell Rogers, shares what the BRAVEHEART registry found at TCT 2026: A large majority of firefighters with no symptoms had plaque in their coronary arteries. Once they saw their own results, most were ready to take action. They look healthy. They feel fine. But their hearts deserve a closer look. Thank you to Dr. Milind Parikh, every firefighter who took part, and everyone who visited us in San Diego. See you at AHA in Chicago!

CT-guided PCI matched IVUS outcomes in P4. In NAVIGATE-PCI, treatment plans changed in approximately 70% of patients after PCI Navigator review. Our Chief Medical Officer, Campbell Rogers, MD, FACC, on what these two studies at TCT2026 means for coronary intervention. Thank you to Dr. Carlos Collet Bortone, principal investigator of P4, and Dr. Ziad Ali, principal investigator of NAVIGATE-PCI, and to every site and patient behind this work. See you at AHA next week.

New one-year data from the prospective DECIDE registry at AHA 2026: Heartflow Plaque Analysis changed medical management in more than half of patients, with faster, more durable LDL-C control and fewer major cardiovascular events compared to CCTA alone.

At #TCT2026, we will present late-breaking data from the P4 randomized trial demonstrating that CT-guided PCI matches gold-standard imaging outcomes with greater efficiency. We will also share NAVIGATE-PCI Registry data showing Heartflow PCI Navigator changed treatment plans in approximately 70% of patients compared to angiography alone. Together, these data support bringing non-invasive, CT-guided PCI planning into routine cath lab practice. See a preview of our presentations: ir.heartflow.com/news-releas… #PCI #InterventionalCardiology

We’re excited to announce our strategic collaboration with Boston Scientific! Together, we will advance CT-guided PCI planning, connecting pre-procedural insights from Heartflow PCI Navigator with Boston Scientific's comprehensive PCI portfolio. Through this collaboration, we aim to support more informed clinical decision-making and advance a more personalized approach to care for patients with coronary artery disease, from diagnosis through treatment.

Attending TCT 2026? Get hands-on with Heartflow FFRCT Analysis, Plaque Analysis, and PCI Navigator in the Physiology Pavilion. Hands-On Sessions: Capped at 40 attendees. 1:1 Leadership Meetings: Schedule time to connect directly with our leadership team during TCT.

Analyze the plaque. Know the risk. Treat with precision. Real-world evidence from the DECIDE Registry is being presented for the first time at AHA 2026. We look forward to diving deeper into the data at our Expert Theater on personalized CAD risk assessment.

Heartflow took part in the "Coronary CT: From Advanced Diagnosis to Integrated Procedural Planning" conference, hosted at Humanitas Gavezzeni e Castelli in Bergamo, Italy. It was a day of meaningful discussion with cardiologists, interventional cardiologists, and cardiac surgeons. Conversations centered on diagnostic precision with Heartflow FFRct Analysis and Heartflow Plaque Analysis, and on guided planning to optimize revascularization strategies and structural interventions. We're proud to support the evolution of precision cardiology alongside leading experts to build more efficient, sustainable clinical pathways for patients.

What does successful CT-guided PCI planning look like when imaging and interventional teams work together? This question is the focus of Episode 13 of @SYSTOLE_live's The Coronary Corner podcast. Drs. @yadersandoval and @esbrilakis are joined by Drs. @RyanMadderMD and Michael Gallagher for a discussion on developing a CT-guided PCI program, including the role of FFRct and how Heartflow PCI Navigator supports procedural planning and training. Tune in to the full episode here: YouTube: youtube.com/watch?v=MmQFI3tD… Spotify: open.spotify.com/episode/7qf… S/B Heartflow. #PCIplanning #CTguidedPCI #PCINavigator

PCI planning has historically happened during the case. What changes when planning happens before the case starts? Two new data sets at TCT2026 look at that question. Join our Lunch Symposium to hear directly from the PIs on what these findings mean for clinical practice.

Congratulations to our Q1 2026 CT Quality Award recipients! This award recognizes institutions in the 90th percentile nationally for CT quality, reflecting their commitment to advancing patient heart health through superior care pathways. We're proud to partner with these teams to help more patients access improved diagnostic pathways and gain a deeper understanding of their cardiovascular health using coronary CTA + Heartflow Analysis. Learn how this approach supports clinical excellence: heartflow.com/ccta-advantage… @advocatehealth @amiradiology @BoulderCHealth @BrowardHealth @ccpdocs @christianacare @CHS_LI @GeisingerHealth @Lee_Health @Memorial_Owosso @MtSinaiQueens @HCAHealthONE @Norton_Health @nyulangone @theprismahealth @ShannonMedical @SimonMedImaging @sdenvercardio @StLukesSTL @uchealth

Two new data sets. Both advancing CT-guided PCI planning. Hear Dr. Campbell Rogers on why TCT 2026 matters this year then see us at Booth #3819. Visit our website to learn more: event.heartflow.com/tct2026

Join us for an Expert Theater with Dr. Mark Rabbat at NLA Fall Clinical Lipid Update 2026 on Saturday, October 3: Implementing CCTA and Heartflow Plaque Analysis to Guide Management of CAD. We'll explore the clinical need to evolve risk assessment through new tools and emerging evidence, and discuss how Heartflow Plaque Analysis and the DECIDE Registry inform management strategies for patients with CAD.